RICE is salvage therapy for treating CD20+non-Hodgkin lymphoma (NHL). It combined with G-CSF to collect autologous peripheral blood stem cells (aPBSC). Little data exists, though, on the combination of and Plerixafor after in mobilizing adequate number CD34 product’s immune content. We report results twenty CD20+ NHL patients RICE, were given aPBSC. The median collected was 12.92 × 10<sup>...
